University College, London: Prostatic Neoplasms trials

The registry lists 29 Prostatic Neoplasms studies with University College, London as lead sponsor. 7 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 4Phase 3 4No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)Not yet recruitingNCT07808528Not applicable
• Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate CancerRecruitingNCT07751133Phase 3
• A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical ProstatectomyRecruitingNCT07541911Not applicable
• ACTinium in Castrate-RESistant Prostate Cancer After LUTEtiumRecruitingNCT07414940Phase 1/2
• Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational StudyNot yet recruitingNCT06145958
• Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate CancerRecruitingNCT05020522Not applicable
• Focal Therapy for Prostate Cancer Using HIFURecruitingNCT01194648Not applicable
• Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.Active, not recruitingNCT03317990Not applicableResults posted
• Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal MicroscopyCompletedNCT06398470Phase 1/2
• ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerActive, not recruitingNCT05653063
• Novel MRI Assessment of Prostate Cancer VALIDATE-PROStatus unknownNCT05017181
• Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.Status unknownNCT04792138
• Prostate Imaging Using MRI +/- Contrast EnhancementActive, not recruitingNCT04571840Not applicable
• Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-ProgressorsActive, not recruitingNCT04340245
• The Prostate Liquid Study (PLiS)Status unknownNCT04102904
• Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate CancerActive, not recruitingNCT04067713
• ReIMAGINE Prostate Cancer ScreeningCompletedNCT04063566Not applicable
• ReIMAGINE Prostate Cancer RiskActive, not recruitingNCT04060589
• UNDISTORT Correction of Distortions in Diffusion MRI V1.0CompletedNCT03151512
• Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic SignatureActive, not recruitingNCT03061539Phase 2
• Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniquesStatus unknownNCT02935816
• Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapyStatus unknownNCT02721784Phase 1/2
• Cancer Diagnosis by Multiparametric UltraSound of the ProstateStatus unknownNCT02712684
• CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancErCompletedNCT02689271
• PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?CompletedNCT02380027Phase 3
• SmartTarget: BIOPSYCompletedNCT02341677Not applicable
• SmartTarget THERAPYStatus unknownNCT02290561Not applicable
• RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryCompletedNCT00541047Phase 3
• Prostate Adenocarcinoma TransCutaneous HormonesStatus unknownNCT00303784Phase 3